Solid Biosciences (SLDB) Current Assets (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Current Assets for 8 consecutive years, with $179.5 million as the latest value for Q3 2024.
- Quarterly Current Assets rose 21.0% to $179.5 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $179.5 million through Sep 2024, up 21.0% year-over-year, with the annual reading at $129.7 million for FY2023, 40.93% down from the prior year.
- Current Assets hit $179.5 million in Q3 2024 for Solid Biosciences, down from $197.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $274.3 million in Q1 2021 to a low of $27.2 million in Q3 2020.
- Historically, Current Assets has averaged $170.6 million across 5 years, with a median of $179.5 million in 2024.
- Biggest five-year swings in Current Assets: crashed 76.07% in 2020 and later soared 779.21% in 2021.
- Year by year, Current Assets stood at $158.9 million in 2020, then surged by 40.09% to $222.6 million in 2021, then decreased by 1.34% to $219.6 million in 2022, then plummeted by 40.93% to $129.7 million in 2023, then skyrocketed by 38.36% to $179.5 million in 2024.
- Business Quant data shows Current Assets for SLDB at $179.5 million in Q3 2024, $197.6 million in Q2 2024, and $214.2 million in Q1 2024.